Impact of COVID-19 on anxiety levels among patients with cancer actively treated with systemic therapy. Issue 5 (23rd October 2020)

• Record Type: Journal Article
• Authors: Sigorski, Dawid; Sobczuk, Paweł; Osmola, Małgorzata; Kuć, Kamil; Walerzak, Anna; Wilk, Michal; Ciszewski, Tomasz; Kopeć, Sylwia; Hryń, Karolina; Rutkowski, Piotr; Stec, Rafał; Szczylik, Cezary; Bodnar, Lubomir
• Is Part Of: ESMO open. Volume 5:Issue 5(2020)
• Publication Date: 2020-10-23
• Subjects: SARS-CoV-2 -- pandemic -- anxiety -- cancer -- treatment; Cancer -- Periodicals; 616.994005
• DOI: 10.1136/esmoopen-2020-000970
• Languages: English
• ISSNs: 2059-7029

Abstract

Abstract : Background: Life-threatening diseases have a negative impact on emotional well-being and psychosocial functioning. This study aimed to assess the relationship between the level of anxiety caused by a neoplasm and the threat of coronavirus infection among patients with cancer actively treated with systemic therapy during the COVID-19 pandemic. Additionally, we searched for clinical factors associated with a higher level of anxiety. Methods: In this multicentre, prospective, non-interventional study conducted in Poland, we enrolled 306 actively treated patients with cancer and collected their clinical data, including age, gender, cancer type and treatment intention. The fear/anxiety of SARS-CoV-2 were rated in Fear of COVID-19 Scale (SRA-FCV-19S) and Numerical Anxiety Scale (SRA-NAS). The fear and anxiety associated with cancer (CRA) were rated with the NAS (CRA-NAS). Results: The mean level of SRA-FCV-19S was 18.5±7.44, which was correlated with the SRA-NAS (r=0.741, p<0.001). SRA-FCV-19S was significantly higher in women versus men (20.18±7.56 vs 16.54±6.83; p<0.001) and was tumour type-dependent (p=0.037), with the highest anxiety observed in patients with breast cancer (17.63±8.75). In the multivariate analysis, only the female gender was significantly associated with higher SRA. CRA-NAS was higher in women versus men (7.07±2.99 vs 5.47±3.01; p<0.001), in patients treated with curative versus palliative intention (7.14±3.06 vs 5.99±3.06; p=0.01) and in individuals aged ≤65 years versus >65 years (6.73±2.96 vs 5.66±3.24; p=0.007). Conclusions: For an actively treated patient with cancer, cancer remains the main life-threatening disease during the COVID-19 pandemic. The need for more attentive psychological care should be provided especially to female patients, patients with breast cancer, those under 65 years of age and treated with curative intention, as these factors are associated with a higher level of anxiety.